Archived
This content is available here strictly for research, reference, and/or recordkeeping and as such it may not be fully accessible. If you work or study at University of Kentucky and would like to request an accessible version, please use the SensusAccess Document Converter.
US Patent Number
5922319
Publication Date
7-13-1999
Abstract
A method of reducing corneal scarring or fibroblast proliferation comprises applying to an area of a subject's eye afflicted with the condition a corneal scar-fibroblast proliferation-reducing amount of a free or polymer-bound HLE inhibitory agent under conditions and for a period of time effective to attain the desired effect. A method of reducing neovascularization of corneal scar tissue comprises applying to an area of a subject's eye afflicted with the condition a neovascularization-inhibitory amount of a free or polymer-bound HLE inhibitory agent under conditions and for a period of time effective to attain the desired effect.
Assignees
University of Kentucky Research Foundation, Lexington, Ky.
Application Number
07/409,894
Filing Date
09/20/1989
Recommended Citation
Digenis, George A. and Khouri, Charles, "Methods of Treating Eye Conditions with Human Leukocyte Elastase (HLE) Inhibitory Agents" (1999). Pharmaceutical Sciences Faculty Patents. 88.
https://uknowledge.uky.edu/ps_patents/88
